BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 39 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $23,696,000 | +17.1% | 18,000,000 | -5.5% | 0.20% | -5.5% |
| Q1 2020 | $20,242,000 | -50.1% | 19,050,000 | -48.8% | 0.22% | -38.5% |
| Q4 2019 | $40,529,000 | +237.7% | 37,223,000 | +272.2% | 0.35% | +117.9% |
| Q2 2017 | $12,001,000 | +1867.4% | 10,000,000 | +1718.2% | 0.16% | +1057.1% |
| Q1 2014 | $610,000 | – | 550,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 5,590,000 | $6,433,196,000 | 1.48% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,450,000 | $14,458,000 | 1.24% |
| LINDEN ADVISORS LP | 20,760,000 | $24,046,000 | 1.05% |
| GUARDIAN LIFE INSURANCE CO OF AMERICA | 8,000,000 | $9,250,000 | 0.72% |
| Man Investments (CH) AG | 900,000 | $1,043,000 | 0.54% |
| Nicholas Investment Partners, LP | 6,600,000 | $7,631,000 | 0.53% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 28,035,000 | $32,497,000 | 0.50% |
| SSI INVESTMENT MANAGEMENT LLC | 2,067,000 | $2,389,000 | 0.23% |
| Calamos Advisors LLC | 23,382,000 | $27,088,000 | 0.19% |
| LOOMIS SAYLES & CO L P | 591,575 | $46,025,000 | 0.12% |